The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Qiao, P., Li, S., Zhang, H., Yao, L., & Wang, F. (2018) · Oncology Reports · doi:10.3892/or.2018.6636 · Cited by 21
RetractedHepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
Keum, N., & Giovannucci, E. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0189-8 · Cited by 2,661
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408
Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Self-citationEndogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., Agdashian, D., Terabe, M., Berzofsky, J. A., Fako, V., et al. (2018) · Science · doi:10.1126/science.aan5931 · Cited by 1,508
Wirbel, J., Pyl, P. T., Kartal, E., Zych, K., Kashani, A., Milanese, A., Fleck, J. S., Voigt, A. Y., Palleja, A., Ponnudurai, R., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0406-6 · Cited by 1,373
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)33041-7 · Cited by 1,277
Identification of a nuclear receptor that is activated by farnesol metabolites
Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Sun, L., Xie, C., Wang, G., Wu, Y., Wu, Q., Wang, X., Liu, J., Deng, Y., Xia, J., Chen, B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0222-4 · Cited by 1,011
Self-citationActivation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 953
Self-citationAPC, Signal transduction and genetic instability in colorectal cancer
Fodde, R., Smits, R., & Clevers, H. (2001) · Nature Reviews Cancer · doi:10.1038/35094067 · Cited by 937
Mudaliar, S., Henry, R. R., Sanyal, A. J., Morrow, L., Marschall, H., Kipnes, M., Adorini, L., Sciacca, C. I., Clopton, P., Castelloe, E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.042 · Cited by 931
Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
Campbell, C., McKenney, P. T., Konstantinovsky, D., Isaeva, O. I., Schizas, M., Verter, J., Mai, C., Jin, W.-B., Guo, C.-J., Violante, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2193-0 · Cited by 901
Gadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870
Bardou, M., Barkun, A. N., & Martel, M. (2013) · Gut · doi:10.1136/gutjnl-2013-304701 · Cited by 815
Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J., & Suchy, F. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011610200 · Cited by 801
Huang, F., Zheng, X., Ma, X., Jiang, R., Zhou, W., Zhou, S., Zhang, Y., Lei, S., Wang, S., Kuang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12896-x · Cited by 789
Pellicciari, R., Fiorucci, S., Camaioni, E., Clerici, C., Costantino, G., Maloney, P. R., Morelli, A., Parks, D. J., & Willson, T. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025529g · Cited by 743
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Fang, S., Suh, J. M., Reilly, S. M., Yu, E., Osborn, O., Lackey, D., Yoshihara, E., Perino, A., Jacinto, S., Lukasheva, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3760 · Cited by 738
Fon Tacer, K., Bookout, A. L., Ding, X., Kurosu, H., John, G. B., Wang, L., Goetz, R., Mohammadi, M., Kuro-o, M., Mangelsdorf, D. J., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0142 · Cited by 700
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76738 · Cited by 693
Self-citationThe bile acid receptor FXR is a modulator of intestinal innate immunity
Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803978 · Cited by 655
Ceramides – Lipotoxic Inducers of Metabolic Disorders
Chaurasia, B., & Summers, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.006 · Cited by 616
Bile acids as carcinogens in human gastrointestinal cancers
Bernstein, H., Bernstein, C., Payne, C. M., Dvorakova, K., & Garewal, H. (2005) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.08.001 · Cited by 611
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
Chiang, J. Y. L., & Ferrell, J. M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00223.2019 · Cited by 580
Hirschfield, G. M., Mason, A., Luketic, V., Lindor, K., Gordon, S. C., Mayo, M., Kowdley, K. V., Vincent, C., Bodhenheimer, H. C., Parés, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.005 · Cited by 576
Pathak, P., Xie, C., Nichols, R. G., Ferrell, J. M., Boehme, S., Krausz, K. W., Patterson, A. D., Gonzalez, F. J., & Chiang, J. Y. L. (2018) · Hepatology · doi:10.1002/hep.29857 · Cited by 567
Self-citationIntestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Jiang, C., Xie, C., Lv, Y., Li, J., Krausz, K. W., Shi, J., Brocker, C. N., Desai, D., Amin, S. G., Bisson, W. H., et al. (2015) · Nature Communications · doi:10.1038/ncomms10166 · Cited by 559
Self-citationThe Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice
Cariou, B., van Harmelen, K., Duran-Sandoval, D., van Dijk, T. H., Grefhorst, A., Abdelkarim, M., Caron, S., Torpier, G., Fruchart, J.-C., Gonzalez, F. J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510258200 · Cited by 552
Self-citationYang, F., Huang, X., Yi, T., Yen, Y., Moore, D. D., & Huang, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1078 · Cited by 488
Fiorucci, S., Antonelli, E., Rizzo, G., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pellicciari, R., & Morelli, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.001 · Cited by 472
Denson, L. A., Sturm, E., Echevarria, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., & Karpen, S. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.25503 · Cited by 460
Kong, B., Wang, L., Chiang, J. Y. L., Zhang, Y., Klaassen, C. D., & Guo, G. L. (2012) · Hepatology · doi:10.1002/hep.25740 · Cited by 456
FXR Regulates Intestinal Cancer Stem Cell Proliferation
Fu, T., Coulter, S., Yoshihara, E., Oh, T. G., Fang, S., Cayabyab, F., Zhu, Q., Zhang, T., Leblanc, M., Liu, S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.036 · Cited by 456
Sawey, E. T., Chanrion, M., Cai, C., Wu, G., Zhang, J., Zender, L., Zhao, A., Busuttil, R. W., Yee, H., Stein, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.040 · Cited by 436
Ahn, S., Jang, S. J., Shim, J. H., Kim, D., Hong, S., Sung, C. O., Baek, D., Haq, F., Ansari, A. A., Lee, S. Y., et al. (2014) · Hepatology · doi:10.1002/hep.27198 · Cited by 424
Colon-Targeted Oral Drug Delivery Systems: Design Trends and Approaches
Amidon, S., Brown, J. E., & Dave, V. S. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0350-9 · Cited by 423
Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
Trabelsi, M.-S., Daoudi, M., Prawitt, J., Ducastel, S., Touche, V., Sayin, S. I., Perino, A., Brighton, C. A., Sebti, Y., Kluza, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8629 · Cited by 400
Liu, Y., Binz, J., Numerick, M. J., Dennis, S., Luo, G., Desai, B., MacKenzie, K. I., Mansfield, T. A., Kliewer, S. A., Goodwin, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18945 · Cited by 398
A Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXR
Downes, M., Verdecia, M. A., Roecker, A. J., Hughes, R., Hogenesch, J. B., Kast-Woelbern, H. R., Bowman, M. E., Ferrer, J.-L., Anisfeld, A. M., Edwards, P. A., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00104-7 · Cited by 390
FXR signaling in the enterohepatic system
Matsubara, T., Li, F., & Gonzalez, F. J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.05.004 · Cited by 381
Self-citationKnisely, A. S., Strautnieks, S. S., Meier, Y., Stieger, B., Byrne, J. A., Portmann, B. C., Bull, L. N., Pawlikowska, L., Bilezikçi, B., Özçay, F., et al. (2006) · Hepatology · doi:10.1002/hep.21287 · Cited by 379
Yan, F., Cao, H., Cover, T. L., Washington, M. K., Shi, Y., Liu, L., Chaturvedi, R., Peek, R. M., Wilson, K. T., & Polk, D. B. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44031 · Cited by 375
An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
Gonzalez, F. J., Jiang, C., & Patterson, A. D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.057 · Cited by 372
Self-citationFifty years of advances in bile acid synthesis and metabolism
Russell, D. W. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800026-jlr200 · Cited by 358
Hofmann, A. F., & Hagey, L. R. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r049437 · Cited by 358
Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice
Kim, I., Morimura, K., Shah, Y., Yang, Q., Ward, J. M., & Gonzalez, F. J. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl249 · Cited by 357
Self-citationIdentification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene
Grober, J., Zaghini, I., Fujii, H., Jones, S. A., Kliewer, S. A., Willson, T. M., Ono, T., & Besnard, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29749 · Cited by 353
Carcinogenicity of deoxycholate, a secondary bile acid
Bernstein, C., Holubec, H., Bhattacharyya, A. K., Nguyen, H., Payne, C. M., Zaitlin, B., & Bernstein, H. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0648-7 · Cited by 351
Patel, K., Harrison, S. A., Elkhashab, M., Trotter, J. F., Herring, R., Rojter, S. E., Kayali, Z., Wong, V. W., Greenbloom, S., Jayakumar, S., et al. (2020) · Hepatology · doi:10.1002/hep.31205 · Cited by 347
Zollner, G., Marschall, H.-U., Wagner, M., & Trauner, M. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060010s · Cited by 335
Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
Prawitt, J., Abdelkarim, M., Stroeve, J. H. M., Popescu, I., Duez, H., Velagapudi, V. R., Dumont, J., Bouchaert, E., van Dijk, T. H., Lucas, A., et al. (2011) · Diabetes · doi:10.2337/db11-0030 · Cited by 326
Self-citationMouse Model of Colonic Adenoma-Carcinoma Progression Based on Somatic Apc Inactivation
Hinoi, T., Akyol, A., Theisen, B. K., Ferguson, D. O., Greenson, J. K., Williams, B. O., Cho, K. R., & Fearon, E. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2735 · Cited by 314
Gallbladder Cancer in the 21st Century
Kanthan, R., Senger, J.-L., Ahmed, S., & Kanthan, S. C. (2015) · Journal of Oncology · doi:10.1155/2015/967472 · Cited by 295
Zhang, S., Wang, J., Liu, Q., & Harnish, D. C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.025 · Cited by 290
Schaap, F. G., van der Gaag, N. A., Gouma, D. J., & Jansen, P. L. M. (2009) · Hepatology · doi:10.1002/hep.22771 · Cited by 284
Bile Acid Metabolism and Signaling
Chiang, J. Y. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00517.x · Cited by 279
Kim, R. D., Sarker, D., Meyer, T., Yau, T., Macarulla, T., Park, J.-W., Choo, S. P., Hollebecque, A., Sung, M. W., Lim, H.-Y., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0555 · Cited by 262
van Mil, S. W. C., Milona, A., Dixon, P. H., Mullenbach, R., Geenes, V. L., Chambers, J., Shevchuk, V., Moore, G. E., Lammert, F., Glantz, A. G., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.015 · Cited by 257
Chen, F., Ma, L., Dawson, P. A., Sinal, C. J., Sehayek, E., Gonzalez, F. J., Breslow, J., Ananthanarayanan, M., & Shneider, B. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207903200 · Cited by 253
Self-citationPathak, P., Liu, H., Boehme, S., Xie, C., Krausz, K. W., Gonzalez, F., & Chiang, J. Y. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.784322 · Cited by 253
Self-citationChen, Y., Wang, X., Wang, J., Yan, Z., & Luo, J. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.063 · Cited by 248
Nuclear Bile Acid Receptor FXR Protects against Intestinal Tumorigenesis
Modica, S., Murzilli, S., Salvatore, L., Schmidt, D. R., & Moschetta, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1791 · Cited by 237
Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy
Jiang, T., Wang, X. X., Scherzer, P., Wilson, P., Tallman, J., Takahashi, H., Li, J., Iwahashi, M., Sutherland, E., Arend, L., et al. (2007) · Diabetes · doi:10.2337/db06-1642 · Cited by 236
Cao, H., Xu, M., Dong, W., Deng, B., Wang, S., Zhang, Y., Wang, S., Luo, S., Wang, W., Qi, Y., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30643 · Cited by 231
Yang, Z.-X., Shen, W., & Sun, H. (2010) · Hepatology International · doi:10.1007/s12072-010-9202-6 · Cited by 226
Maran, R. R. M., Thomas, A., Roth, M., Sheng, Z., Esterly, N., Pinson, D., Gao, X., Zhang, Y., Ganapathy, V., Gonzalez, F. J., et al. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145409 · Cited by 220
Self-citationThe Farnesoid X Receptor Controls Gene Expression in a Ligand- and Promoter-selective Fashion
Lew, J.-L., Zhao, A., Yu, J., Huang, L., de Pedro, N., Peláez, F., Wright, S. D., & Cui, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306422200 · Cited by 213
An Intestinal Farnesoid X Receptor–Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice
Xie, C., Jiang, C., Shi, J., Gao, X., Sun, D., Sun, L., Wang, T., Takahashi, S., Anitha, M., Krausz, K. W., et al. (2017) · Diabetes · doi:10.2337/db16-0663 · Cited by 201
Self-citationBile Acids Activate YAP to Promote Liver Carcinogenesis
Anakk, S., Bhosale, M., Schmidt, V. A., Johnson, R. L., Finegold, M. J., & Moore, D. D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.030 · Cited by 196
Fiorucci, S., Rizzo, G., Antonelli, E., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pruzanski, M., Morelli, A., & Pellicciari, R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084905 · Cited by 183
STAT proteins – Key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver
Gao, B., Wang, H., Lafdil, F., & Feng, D. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.029 · Cited by 177
Rizzo, G., Sante, M. D., Mencarelli, A., Renga, B., Gioiello, A., Pellicciari, R., & Fiorucci, S. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023820 · Cited by 169
Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults
Campbell, P. T., Newton, C. C., Freedman, N. D., Koshiol, J. E., Alavanja, M. C. R., Freeman, L. E. B., Buring, J. E., Chan, A. T., Chong, D. Q., Datta, M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0787 · Cited by 165
Wolfe, A. R., Thomas, A., Edwards, G., Jaseja, R., Guo, G. L., & Apte, U. M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179390 · Cited by 158
Im, E., & Martinez, J. D. (2004) · Journal of Nutrition · doi:10.1093/jn/134.2.483 · Cited by 154
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
Zhou, J., Cui, S., He, Q., Guo, Y., Pan, X., Zhang, P., Huang, N., Ge, C., Wang, G., Gonzalez, F. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14138-6 · Cited by 154
Self-citationGottardi, A. D., Touri, F., Maurer, C. A., Perez, A., Maurhofer, O., Ventre, G., Bentzen, C. L., Bentzen, E. J., & Dufour, J. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000034558.78747.98 · Cited by 142
Zweers, S. J. L. B., Booij, K. A. C., Komuta, M., Roskams, T., Gouma, D. J., Jansen, P. L. M., & Schaap, F. G. (2011) · Hepatology · doi:10.1002/hep.24702 · Cited by 141
Prediagnostic Plasma Bile Acid Levels and Colon Cancer Risk: A Prospective Study
Kuhn, T. E., Stępień, M., López‐Nogueroles, M., Damms-Machado, A., Sookthai, D., Johnson, T., Roca, M., Hüsing, A., Maldonado, S. G., Cross, A. J., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz166 · Cited by 141
Yamada, S., Takashina, Y., 渡辺, 光., Nagamine, R., Saito, Y., Kamada, N., & Saito, H. (2018) · Oncotarget · doi:10.18632/oncotarget.24066 · Cited by 140
Gadaleta, R. M., García‐Irigoyen, O., Cariello, M., Scialpi, N., Peres, C., Vetrano, S., Fiorino, G., Danese, S., Ko, B., Luo, J., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102719 · Cited by 133
Genome‐wide analysis of gene expression in human intrahepatic cholangiocarcinoma†
Obama, K., Ura, K., Li, M., Katagiri, T., Tsunoda, T., Nomura, A., Satoh, S., Nakamura, Y., & Furukawa, Y. (2005) · Hepatology · doi:10.1002/hep.20718 · Cited by 130
Regulation of the mouse organic solute transporter α-β, Ostα-Ostβ, by bile acids
Frankenberg, T., Rao, A., Chen, F., Haywood, J., Shneider, B. L., & Dawson, P. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00479.2005 · Cited by 125
Wu, W., Zhu, B., Peng, X., Zhou, M., Jia, D., & Gu, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.057 · Cited by 119
Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review
Kimhofer, T., Fye, H. K. S., Taylor-Robinson, S. D., Thursz, M. R., & Holmes, E. C. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.38 · Cited by 117
Su, H., Ma, C., Liu, J., Li, N., Gao, M., Huang, A., Wang, X., Huang, W., & Huang, X. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00439.2011 · Cited by 117
Obeticholic acid-a new therapy in PBC and NASH
Chapman, R. W., & Lynch, K. D. (2020) · British Medical Bulletin · doi:10.1093/bmb/ldaa006 · Cited by 116
Primary biliary cirrhosis and cancer risk: A systematic review and meta-analysis
Liang, Y., Yang, Z., & Zhong, R. (2012) · Hepatology · doi:10.1002/hep.25788 · Cited by 116
Obeticholic Acid: First Global Approval
Markham, A., & Keam, S. J. (2016) · Drugs · doi:10.1007/s40265-016-0616-x · Cited by 116
Pectin/Zein Beads for Potential Colon-Specific Drug Delivery: Synthesis andin VitroEvaluation
Liu, L., Fishman, M. L., Hicks, K. B., et al. (2006) · Drug Delivery · doi:10.1080/10717540500394935 · Cited by 113
Nuclear Receptor Control of Enterohepatic Circulation
Gonzalez, F. J. (2012) · Comprehensive physiology · doi:10.1002/cphy.c120007 · Cited by 110
Self-citationMilona, A., Owen, B. M., Cobbold, J., Willemsen, E. C. L., Cox, I. J., Boudjelal, M., Cairns, W. J., Schoonjans, K., Taylor-Robinson, S. D., Klomp, L. W. J., et al. (2010) · Hepatology · doi:10.1002/hep.23849 · Cited by 108
Lax, S., Schauer, G., Prein, K., Kapitan, M., Silbert, D., Berghold, A., Berger, A., & Trauner, M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26293 · Cited by 107
Zhao, H., Lv, F., Liang, G., Huang, X., Wu, G., Zhang, W., Yu, L., Shi, L., & Teng, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.6185 · Cited by 105
Popescu, I. R., Helleboid‐Chapman, A., Lucas, A., Vandewalle, B., Dumont, J., Bouchaert, E., Derudas, B., Kerr-Conte, J. A., Caron, S., Pattou, F. N., et al. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.068 · Cited by 104
Huang, X., Zhao, W., & Huang, W. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.117 · Cited by 102
Modica, S., Gofflot, F., Murzilli, S., D’Orazio, A., Salvatore, L., Pellegrini, F., Nicolucci, A., Tognoni, G., Copetti, M., Valanzano, R., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.060 · Cited by 102
Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15
Zhou, M., Luo, J., Chen, M., Yang, H., Learned, R. M., DePaoli, A. M., Tian, H., & Ling, L. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.027 · Cited by 102
Western Diet Deregulates Bile Acid Homeostasis, Cell Proliferation, and Tumorigenesis in Colon
Đermadi, D., Valo, S., Ollila, S., Soliymani, R., Sipari, N., Pussila, M., Sarantaus, L., Lindén, J., Baumann, M., & Nyström, M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2860 · Cited by 101
Attia, Y. M., Tawfiq, R. A., Ali, A. A., & Elmazar, M. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-12629-4 · Cited by 96
Zhong, X., Yu, J., Zhang, W., Wang, Z., Dong, Q., Tai, S., Cui, Y., & Li, H. (2011) · Gene · doi:10.1016/j.gene.2011.11.028 · Cited by 93
Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis
Yu, J., Li, S., Guo, J. H., Xu, Z., Zheng, J., & Sun, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02819-w · Cited by 93
Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer
Liu, T., Yang, H., Fan, W., Tu, J., Li, T. W. H., Wang, J., Shen, H., Yang, J., Xiong, T., Steggerda, J. A., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.032 · Cited by 91
Ileal FGF 15 contributes to fibrosis‐associated hepatocellular carcinoma development
Uriarte, I., Latasa, M. U., Carotti, S., Fernández‐Barrena, M. G., García‐Irigoyen, O., Elizalde, M., Urtasun, R., Gentilucci, U. V., Morini, S., Pulido, Á. D. M., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29287 · Cited by 89
FXR silencing in human colon cancer by DNA methylation and KRAS signaling
Bailey, A. M., Zhan, L., Maru, D. M., Shureiqi, I., Pickering, C. R., Kiriakova, G. M., Izzo, J. G., He, N., Wei, C., Baladandayuthapani, V., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00234.2013 · Cited by 89
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression
Erice, O., Labiano, I., Arbelaiz, A., Santos‐Laso, Á., Muñoz-Garrido, P., Jiménez-Agüero, R., Olaizola, P., Caro‐Maldonado, A., Martín-Martín, N., Carracedo, A., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.016 · Cited by 86
Deuschle, U., Schüler, J. B., Schulz, A., Schlüter, T., Kinzel, O. D., Abel, U. R., & Kremoser, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043044 · Cited by 85
Shah, S. A., Volkov, Y., Arfin, Q., Abdel-Latif, M., & Kelleher, D. P. (2005) · International Journal of Cancer · doi:10.1002/ijc.21365 · Cited by 85
Ducastel, S., Touche, V., Trabelsi, M.-S., Boulinguiez, A., Butruille, L., Nawrot, M., Peschard, S., Chávez-Talavera, O., Dorchies, E., Vallez, E., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-56743-x · Cited by 84
Nonsteroidal FXR Ligands: Current Status and Clinical Applications
Gege, C., Hambruch, E., Hambruch, N., Kinzel, O., & Kremoser, C. (2019) · Handbook of Experimental Pharmacology · doi:10.1007/164_2019_232 · Cited by 83
Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage
Gai, Z., Chu, L., Xu, Z., Song, X., Sun, D., & Kullak-Ublick, G. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-10168-6 · Cited by 83
Primary biliary cholangitis: Old and novel therapy
Floreani, A., & Mangini, C. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.06.020 · Cited by 82
Cocarcinogenic Effects of Intrahepatic Bile Acid Accumulation in Cholangiocarcinoma Development
Lozano, E., Sanchez‐Vicente, L., Monte, M. J., Herráez, E., Briz, Ó., Bañales, J. M., Marı́n, J. J. G., & Macı́as, R. I. R. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0503 · Cited by 80
Kubota, K., Sumi, S., Tojo, H., Sumi-Inoue, Y., I-chin, H., Oi, Y., Fujita, H., & Urata, H. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.05.004 · Cited by 76
An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers
Al-Khaifi, A., Rudling, M. J., & Angelin, B. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.038 · Cited by 66
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma
Matteo, S. D., Nevi, L., Costantini, D., Overi, D., Carpino, G., Safarikia, S., Giulitti, F., Napoletano, C., Manzi, E., Rose, A. M. D., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210077 · Cited by 66
Obeticholic acid may increase the risk of gallstone formation in susceptible patients
Al-Dury, S., Wahlstrom, A. M., Panzitt, K., Thorell, A., Ståhlman, M., Trauner, M., Fickert, P., Bäckhed, F., Fändriks, L., Wagner, M., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.011 · Cited by 66
Khare, S., Mustafi, R., Cerda, S., Yuan, W., Jagadeeswaran, S., Dougherty, U., Tretiakova, M., Samarel, A. M., Cohen, G., Wang, J., et al. (2008) · Nutrition and Cancer · doi:10.1080/01635580701883003 · Cited by 64
Activation of FXR protects against renal fibrosis via suppressing Smad3 expression
Zhao, K., He, J., Zhang, Y., Xu, Z., Xiong, H., Gong, R., Li, S., Chen, S., & He, F. (2016) · Scientific Reports · doi:10.1038/srep37234 · Cited by 64
Kim, E., Cho, J. H., Kim, E. J., & Kim, Y. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181183 · Cited by 64
Nuclear bile acid receptor FXR in the hepatic regeneration
Chen, W., Wang, Y., Meng, Z., Zhang, L., & Huang, W. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.006 · Cited by 63
Manley, S., Ni, H., Williams, J. A. R., Kong, B., DiTacchio, L., Guo, G. L., & Ding, W. (2014) · Redox Biology · doi:10.1016/j.redox.2014.08.007 · Cited by 61
He, J., Zhao, K., Zheng, L., Xu, Z., Gong, W., Chen, S., Shen, X., Huang, G., Gao, M., Zeng, Y., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0427-9 · Cited by 61
Peng, Z., Raufman, J., & Xie, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048461 · Cited by 57
Gadaleta, R. M., Scialpi, N., Peres, C. M., Cariello, M., Ko, B., Luo, J., Porru, E., Roda, A., Sabbà, C., & Moschetta, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-35496-z · Cited by 57
Selmin, O. I., Fang, C., Lyon, A. M., Doetschman, T. C., Thompson, P. A., Martinez, J. D., Smith, J. W., Lance, P., & Romagnolo, D. F. (2015) · Journal of Nutrition · doi:10.3945/jn.115.216580 · Cited by 56
Kong, B., Zhu, Y., Li, G., Williams, J. A. R., Buckley, K., Tawfik, O. W., Luyendyk, J. P., & Guo, G. L. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00134.2015 · Cited by 56
Chen, J., Du, F., Dang, Y., Li, X., Qian, M., Feng, W., Qiao, C., Fan, D., Nie, Y., Wu, K., et al. (2019) · Hepatology · doi:10.1002/hep.30951 · Cited by 55
Liao, M., Zhao, J., Wang, T., Duan, J., Zhang, Y., & Deng, X. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-44 · Cited by 54
Kong, B., Sun, R., Huang, M., Chow, M. D., Zhong, X., Xie, W., Lee, Y., & Guo, G. L. (2018) · Hepatology · doi:10.1002/hep.30041 · Cited by 52
FXR induces SOCS3 and suppresses hepatocellular carcinoma
Guo, F., Xu, Z., Zhang, Y., Jiang, P., Huang, G., Chen, S., Lyu, X., Zheng, P., Zhao, X., Zeng, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5314 · Cited by 51
Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development
Takahashi, S., Tanaka, N., Fukami, T., Xie, C., Yagai, T., Kim, D., Velenosi, T. J., Yan, T., Krausz, K. W., Levi, M., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1263 · Cited by 50
Self-citationLü, W., Cheng, F., Jiang, J., Zhang, C., Deng, X., Xu, Z., Zou, S., Shen, X., Tang, Y., & Huang, J. Y. (2015) · Scientific Reports · doi:10.1038/srep08114 · Cited by 48
Cariello, M., Peres, C. M., Zerlotin, R., Porru, E., Sabbà, C., Roda, A., & Moschetta, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-11549-7 · Cited by 47
Kang, H. J., Haq, F. U., Sung, C. O., Choi, J., Hong, S., Eo, S., Jeong, H. J., Shin, J., Shim, J. H., Lee, H. C., et al. (2018) · Liver Cancer · doi:10.1159/000488541 · Cited by 45
Farnesoid X receptor associates with β-catenin and inhibits its activity in hepatocellular carcinoma
Liu, X., Zhang, X., Ji, L., Gu, J., Zhou, M., & Chen, S. (2015) · Oncotarget · doi:10.18632/oncotarget.2899 · Cited by 44
Farnesoid-X Receptor (FXR) as a Promising Pharmaceutical Target in Atherosclerosis
Moris, D., Giaginis, C., Tsourouflis, G. S., & Theocharis, S. E. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170124151940 · Cited by 42
Peng, Z., Chen, J., Drachenberg, C. B., Raufman, J., & Xie, G. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004361 · Cited by 40
Wang, W., Zhan, M., Li, Q., Chen, W., Chu, H., Huang, Q., Hou, Z., Man, M., & Wang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8964 · Cited by 33
Li, Q., Zhao, Q., Zhang, C., Zhang, P., Hu, A., Zhang, L., Schroder, P. M., Ma, Y., Guo, Z., Zhu, X., et al. (2018) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-018-0610-8 · Cited by 31
Treatment options for nonalcoholic steatohepatitis - a safety evaluation
Issa, D., Wattacheril, J. J., & Sanyal, A. J. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1343299 · Cited by 30
Lee, Y. J., Lee, E., Choi, B. H., Jang, H., Myung, J., & You, H. J. (2020) · PubMed Central · doi:10.14348/molcells.2020.0041 · Cited by 25
Takahashi, S., Tanaka, N., Golla, S., Fukami, T., Krausz, K. W., Polunas, M., Weig, B., Masuo, Y., Xie, C., Jiang, C., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx094 · Cited by 24
Self-citationModica, S., Cariello, M., Morgano, A., Groß, I., Vegliante, M. C., Murzilli, S., Salvatore, L., Freund, J., Sabbà, C., & Moschetta, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.571513 · Cited by 23
FXR Agonists as Therapy for Liver Disease
Hoofnagle, J. H. (2020) · Hepatology · doi:10.1002/hep.31265 · Cited by 21
Zuo, M., Rashid, A., Wang, Y., Jain, A., Li, D., Behari, A., Kapoor, V. K., Koay, E. J., Chang, P., Vauthey, J. N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9181 · Cited by 20
Peng, Y., Chen, J., He, S., Yang, J., & Wu, H. (2012) · PLoS ONE · doi:10.1371/annotation/7f401244-ab06-4243-8688-5c987ddca311 · Cited by 19
Nijmeijer, R. M., Schaap, F. G., Smits, A. J. J., Kremer, A. E., Akkermans, L. M. A., Kroese, A. B. A., Rijkers, G. T., Schipper, M. E. I., Verheem, A., Wijmenga, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114393 · Cited by 17
Souris, J. S., Zhang, H. J., Dougherty, U., Chen, N., Waller, J. V., Lo, L., Hart, J. A. L., Chen, C.-T., & Bissonnette, M. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz050 · Cited by 14
Cited by
Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis
Cai, J., Sun, L., & Gonzalez, F. J. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.02.004 · Cited by 843
Self-citationImmune cell-mediated features of non-alcoholic steatohepatitis
Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway
Nie, Q., Luo, X., Wang, K., Ding, Y., Jia, S., Zhao, Q., Li, M., Zhang, J., Zhuo, Y., Lin, J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.034 · Cited by 326
Self-citationKuang, J., Wang, J., Li, Y., Li, M., Zhao, M., Ge, K., Zheng, D., Cheung, K. C. P., Liao, B., Wang, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.011 · Cited by 321
Metadata
- Authors
- Sun, L., Cai, J., & Gonzalez, F. J.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2021-02-10
- Volume
- 18
- Issue
- 5
- Pages
- 335-347
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W3128019435
- Cited by
- 435
- References
- 161
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.